ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

IDH Immunodiagnostic Systems Holdings Plc

378.00
0.00 (0.00%)
Last Updated: 00:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Immunodiagnostic Systems Holdings Plc LSE:IDH London Ordinary Share GB00B01YZ052 ORD 2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 378.00 0.00 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Immunodiagnostic Systems Hldgs PLC Additional Listing to Correct Discrepancy (6449A)

03/06/2021 7:00am

UK Regulatory


Immunodiagnostic Systems (LSE:IDH)
Historical Stock Chart


From Mar 2021 to Mar 2024

Click Here for more Immunodiagnostic Systems Charts.

TIDMIDH

RNS Number : 6449A

Immunodiagnostic Systems Hldgs PLC

03 June 2021

3 June 2021

Immunodiagnostic Systems Holdings plc

Additional Listing to Correct Historical Discrepancy

Immunodiagnostic Systems Holdings plc ("IDS" or the "Company") (LSE: IDH) today announces that an application has been made to the London Stock Exchange for the admission of 102,674 ordinary shares of 10p each ('Ordinary Shares') in IDS in order to correct a historical discrepancy between its issued share capital and the share capital recorded as having been admitted to trading on AIM.

On 10 May 2010, IDS announced the issue and allotment of 2,674 Ordinary Shares to satisfy an exercise of options and on 29 June 2011 IDS announced the issue and allotment of 100,000 Ordinary Shares to satisfy an exercise of options. In both cases a listing application was not submitted due to an administrative oversight and therefore 102,674 Ordinary Shares were not admitted to trading on AIM at that time. It is expected that the 102,674 Ordinary Shares will be admitted to trading on 8 June 2021.

No new Ordinary Shares have been issued or allotted and IDS confirms that its issued share capital remains unchanged at 28,784,097 Ordinary Shares as at 2 June 2021 (excluding 627,078 IDS Shares held in treasury).

For further information please contact:

   Immunodiagnostic Systems Holdings plc                          Tel : +44 (0)191 5190660 

Paul Martin, Group Finance Director

Peel Hunt LLP Tel : +44 (0)207 418 8900

James Steel

Victoria Erskine

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ALSUUUBRANUNRAR

(END) Dow Jones Newswires

June 03, 2021 02:00 ET (06:00 GMT)

1 Year Immunodiagnostic Systems Chart

1 Year Immunodiagnostic Systems Chart

1 Month Immunodiagnostic Systems Chart

1 Month Immunodiagnostic Systems Chart

Your Recent History

Delayed Upgrade Clock